ES2610990T3 - Secuencias de expresión - Google Patents

Secuencias de expresión Download PDF

Info

Publication number
ES2610990T3
ES2610990T3 ES13785840.3T ES13785840T ES2610990T3 ES 2610990 T3 ES2610990 T3 ES 2610990T3 ES 13785840 T ES13785840 T ES 13785840T ES 2610990 T3 ES2610990 T3 ES 2610990T3
Authority
ES
Spain
Prior art keywords
epxl
sequence
secretion
protein
pastoris
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13785840.3T
Other languages
English (en)
Spanish (es)
Inventor
Brigitte Gasser
Diethard Mattanovich
Silvia HEISS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Application granted granted Critical
Publication of ES2610990T3 publication Critical patent/ES2610990T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478Aspartic endopeptidases (3.4.23)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
ES13785840.3T 2012-10-29 2013-10-29 Secuencias de expresión Active ES2610990T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12190361 2012-10-29
EP12190361 2012-10-29
PCT/EP2013/072572 WO2014067926A1 (fr) 2012-10-29 2013-10-29 Séquences d'expression

Publications (1)

Publication Number Publication Date
ES2610990T3 true ES2610990T3 (es) 2017-05-04

Family

ID=47115533

Family Applications (2)

Application Number Title Priority Date Filing Date
ES13785840.3T Active ES2610990T3 (es) 2012-10-29 2013-10-29 Secuencias de expresión
ES16184950T Active ES2789299T3 (es) 2012-10-29 2013-10-29 Secuencias de expresión

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES16184950T Active ES2789299T3 (es) 2012-10-29 2013-10-29 Secuencias de expresión

Country Status (17)

Country Link
US (2) US10160988B2 (fr)
EP (2) EP2912053B1 (fr)
JP (2) JP6556625B2 (fr)
KR (1) KR102079293B1 (fr)
CN (1) CN104837857B (fr)
AU (1) AU2013341049B2 (fr)
BR (1) BR112015008289A2 (fr)
CA (2) CA3212565A1 (fr)
DK (1) DK2912053T3 (fr)
ES (2) ES2610990T3 (fr)
HK (1) HK1208037A1 (fr)
HU (1) HUE033282T2 (fr)
IL (2) IL238420B (fr)
IN (1) IN2015DN02771A (fr)
PL (1) PL2912053T3 (fr)
SG (1) SG11201502745XA (fr)
WO (1) WO2014067926A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2610990T3 (es) * 2012-10-29 2017-05-04 Lonza Ltd Secuencias de expresión
CN104312933B (zh) * 2014-10-17 2017-03-29 江南大学 一种优化信号肽提高胰蛋白酶胞外分泌表达的方法
CN108350447B (zh) * 2015-08-05 2021-08-31 龙沙有限公司 启动子变体
EP3423588A1 (fr) 2016-03-02 2019-01-09 Lonza Ltd Procédé de fermentation amélioré
KR20240005134A (ko) * 2017-03-10 2024-01-11 볼트 쓰레즈, 인크. 재조합 단백질을 고분비 수율로 생산하기 위한 조성물 및 방법
CA3072134A1 (fr) 2017-05-31 2018-12-06 Universitat Fur Bodenkultur Wien Levure exprimant un cycle de calvin synthetique
KR20200120908A (ko) 2018-02-12 2020-10-22 론자 리미티드 목적 단백질을 생산하기 위한 숙주 세포
US20210388037A1 (en) 2018-11-19 2021-12-16 Basf Se Leader sequence for yeast
ES2921137T3 (es) 2019-01-11 2022-08-18 Lonza Ag Producción de proteínas regulada por fuente de carbono en una célula huésped recombinante
WO2020200415A1 (fr) 2019-04-01 2020-10-08 Lonza Ltd Levure mut-méthylotrophe
WO2020200414A1 (fr) 2019-04-01 2020-10-08 Lonza Ltd Production de protéines dans de la levure mut-méthylotrophe
CN114026239A (zh) 2019-04-01 2022-02-08 维也纳自然资源与生命科学大学 Mut-甲醇营养型酵母
CN110760003A (zh) * 2019-09-10 2020-02-07 广东药科大学 一种抗her3单链抗体的制备方法
WO2021198431A1 (fr) 2020-04-01 2021-10-07 Lonza Ltd Facteurs auxiliaires pour exprimer des protéines dans une levure
CN116490517A (zh) 2020-09-30 2023-07-25 龙沙有限公司 过表达翻译因子的宿主细胞
EP4271794A2 (fr) 2020-12-29 2023-11-08 bisy GmbH Nouvelles souches de levure

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0118551A1 (fr) 1982-09-15 1984-09-19 Collaborative Research Inc. Production d'interferon dans une levure par l'utilisation d'un promoteur d'invertase
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
CA1340772C (fr) 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression et secretion de proteines heterologues dans une levure au moyen de sequences leader tronquees du facteur alpha
EP0438200B1 (fr) 1990-01-16 2002-07-17 Centro De Ingenieria Genetica Y Biotecnologia Méthode d'expression de gènes hétérologues dans la levure Pichia pastoris, vecteurs d'expression et microorganismes transformés
US5268273A (en) 1990-12-14 1993-12-07 Phillips Petroleum Company Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same
DK82893D0 (da) 1993-07-08 1993-07-08 Novo Nordisk As Peptid
EA017803B1 (ru) 2007-04-20 2013-03-29 Полимун Сайнтифик Иммунбиологише Форшунг Гмбх Система экспрессии
US7741075B2 (en) 2008-06-06 2010-06-22 Board Of Regents Of The University Of Nebraska Pichia pastoris PIR1 secretion signal peptide for recombinant protein expression and Pichia pastoris PIR1 and PIR2 anchor domain peptides for recombinant surface display
US8440456B2 (en) * 2009-05-22 2013-05-14 Vib, Vzw Nucleic acids of Pichia pastoris and use thereof for recombinant production of proteins
EP2258855A1 (fr) * 2009-05-28 2010-12-08 Universität für Bodenkultur Wien Séquences d'expression
DE102009055015B4 (de) 2009-12-18 2013-12-24 Technische Universität Dresden Hefe-Sekretionssystem auf Basis einer Signalsequenz aus der Hydrophobin 1-Gensequenz von Trichoderma reesei
WO2012152823A1 (fr) * 2011-05-09 2012-11-15 Ablynx Nv Procédé pour la production de domaines variables uniques d'immunoglobuline
ES2610990T3 (es) * 2012-10-29 2017-05-04 Lonza Ltd Secuencias de expresión

Also Published As

Publication number Publication date
EP3130598A2 (fr) 2017-02-15
DK2912053T3 (en) 2017-01-30
CN104837857B (zh) 2018-11-06
KR20150076160A (ko) 2015-07-06
EP2912053B1 (fr) 2016-11-09
JP2015533286A (ja) 2015-11-24
CA3212565A1 (fr) 2014-05-08
WO2014067926A1 (fr) 2014-05-08
US10160988B2 (en) 2018-12-25
PL2912053T3 (pl) 2017-05-31
IL238420B (en) 2019-05-30
AU2013341049B2 (en) 2017-07-20
JP2019141063A (ja) 2019-08-29
US20180135092A1 (en) 2018-05-17
US11359223B2 (en) 2022-06-14
CA2886460A1 (fr) 2014-05-08
HK1208037A1 (en) 2016-02-19
CA2886460C (fr) 2023-11-14
US20150232904A1 (en) 2015-08-20
AU2013341049A1 (en) 2015-04-02
IN2015DN02771A (fr) 2015-09-04
JP6556625B2 (ja) 2019-08-07
ES2789299T3 (es) 2020-10-26
IL266700A (en) 2019-07-31
CN104837857A (zh) 2015-08-12
SG11201502745XA (en) 2015-05-28
EP3130598A3 (fr) 2017-05-03
IL266700B (en) 2021-08-31
BR112015008289A2 (pt) 2017-11-28
HUE033282T2 (en) 2017-11-28
EP3130598B1 (fr) 2020-02-12
IL238420A0 (en) 2015-06-30
KR102079293B1 (ko) 2020-02-19
EP2912053A1 (fr) 2015-09-02

Similar Documents

Publication Publication Date Title
ES2610990T3 (es) Secuencias de expresión
AU2015248815B2 (en) Recombinant host cell engineered to overexpress helper proteins
US20210269811A1 (en) Means and methods for increased protein expression by use of transcription factors
TW202031898A (zh) 重組宿主細胞中的碳源調控蛋白質製造
EP2952585A1 (fr) Production de protéines améliorées dans des champignons ou des levures
JP2023156329A (ja) 目的タンパク質を産生するための宿主細胞
US20240141363A1 (en) Signal peptides for increased protein secretion
CA2749571A1 (fr) Proteines de fusion, procede pour leur preparation et leur utilisation dans des systemes d'expression de proteines recombinantes
JP2023543604A (ja) 翻訳因子を過剰発現する宿主細胞